IPO GMP comparison: Jio Platforms and Paras Healthcare were the two major IPOs that opened for subscription on October 21, drawing contrasting responses from investors. While Jio Platforms dominated market attention with strong demand, Paras Healthcare witnessed a relatively subdued response.
The grey market premium (GMP) of Jio Platforms’ IPO eased slightly to ₹246 from ₹273, but the issue continues to command a strong premium in the unlisted market. According to Investorgain, the mega IPO’s GMP stood at ₹246.
Meanwhile, Paras Healthcare IPO GMP trends remained weak. The GMP of Paras Healthcare IPO stood at ₹25, as per data available on Investorgain
According to current GMP trends, Jio Platforms’ IPO is expected to list at around ₹1,365 per share, implying a potential listing gain of 21.98% over the upper issue price of ₹1,119.
On the other hand, the estimated listing price of Paras Healthcare IPO is likely to be ₹718, which is 3.61% higher than the IPO price of ₹693.